Skip to content

Jin Zhang

Merck & Co., Inc., Rahway, NJ, USA (United States)

1 paper in the Anchorcite directory, published in 2015, cited 6,294 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Edward B. Garon · 1 paper
  • Naiyer A. Rizvi · 1 paper
  • Rina Hui · 1 paper
  • Natasha B. Leighl · 1 paper
  • Ani Sarkis Balmanoukian · 1 paper
  • Joseph P. Eder · 1 paper
  • Amita Patnaik · 1 paper
  • Charu Aggarwal · 1 paper

Papers

  1. Pembrolizumab for the Treatment of Non–Small-Cell Lung CancerNew England Journal of Medicine · 2015 · 6,294 citations

    BACKGROUND: We assessed the efficacy and safety of programmed cell death 1 (PD-1) inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled in a phase 1 study. We also sought to define and validate an expression level of…

Metadata from OpenAlex (CC0).